[Clinical picture and treatment of the Raynaud syndrome of the upper extremities].
Raynaud's disease occurs in different clinical forms, which are not specific to the vascular spasm which characterizes the disease. This spasm virtually always develops in the same manner. Clinical aspects depend on the underlying pathology, which will define treatment. Therapeutic efficacy in Raynaud's disease is discussed. Current interest focuses on serotonin antagonists.
D003080:Cold Temperature / Q000009:adverse effects; D005385:Fingers / Q000098:blood supply*; D006801:Humans; D009257:Nafronyl / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D011928:Raynaud Disease / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D012702:Serotonin Antagonists / Q000627:therapeutic use
D011759:Pyrrolidines; D011942:Receptors, Adrenergic, alpha; D012702:Serotonin Antagonists; D009257:Nafronyl; C010651:buflomedil
Clinique et thérapeutique du syndrome de Raynaud des membres supérieurs.